Riskpilot← Back to searchSign inGet full accessMEDIN AS
ASActiveOrg 821601002Jærgata 22, 4012 StavangerOther human health activities n.e.c. · NACE 8699Est. 20180 employees
Revenue 2024
NOK 295K
+3772% vs 2023
EBITDA margin
-97.2%
-12% vs 2023
Equity ratio
97.7%
Financial strength
Net profit 2024
NOK 5,2M
+28% vs 2023
| Revenue | NOK 295K | +3772% |
| EBITDA | NOK -287K | -12% |
| Net profit | NOK 5,2M | +28% |
| Total assets | NOK 52,1M | +29% |
| Equity | NOK 50,9M | +26% |
| Employees | 0 | — |
Legal name
MEDIN AS
Org number
821601002
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
24. oktober 2018
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utøvelse av bedriftshelsetjenester, samt salg av produkter og øvrige tjenester innenfor bedriftshelsemarkedet. Selskapet vil også utøve investeringer i eiendom, finans og aksjemarkedet. Selskapet vil også kunne delta i øvrige selskaper hva hermed er forbundet med.
Address
Jærgata 22, 4012 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 14 | 8 | 295 |
| Staff expenses | −0 | −0 | −0 | −10 | −14 |
| EBITDA | −37 | −264 | −225 | −256 | −287 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −164 |
| EBIT | −37 | −264 | −225 | −256 | −451 |
| Net financials | 2 477 | 2 286 | −1 918 | 4 365 | 5 664 |
| Profit before tax | 2 439 | 2 021 | −2 143 | 4 109 | 5 212 |
| Tax | −0 | 70 | −0 | 35 | −0 |
| Net profit | 2 439 | 1 951 | −2 143 | 4 074 | 5 212 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 36 443 | 38 465 | 36 252 | 40 361 | 52 091 |
| Equity | 36 413 | 38 365 | 36 222 | 40 295 | 50 898 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 054 |
| Short-term debt | 30 | 100 | 30 | 65 | 139 |
| Total debt | 30 | 100 | 30 | 65 | 1 193 |
EBITDA margin
-97.2%
This company
15.8%
Market median
-715% vs market
20202024
Equity ratio
97.7%
This company
38.2%
Market median
+156% vs market
20202024
Return on equity
10.2%
This company
18.4%
Market median
+45% vs market
20202024
Net profit margin
1764.2%
This company
8.1%
Market median
+21680% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GB Chief Executive Officer | Chief Executive Officer | 2018 |
ML Deputy Member | Deputy Member | 2018 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDIN AS 
Medin Helse AsBoard members of MEDIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gaute Bjaanes | Chief Executive Officer | 0 companies |
| Margaret Lavik | Deputy Member | 0 companies |